Previous Page  95 / 148 Next Page
Information
Show Menu
Previous Page 95 / 148 Next Page
Page Background

93

(

`

cr)

NOTE 27.5 (B) TRANSACTIONS WITH SUBSIDIARY COMPANIES

(contd)

2013-14

2012-13

6 Reimbursement

12.15

3.17

Ameer Trading Corporation Ltd

0.66

–

Atul Bioscience Ltd (Previous year:

`

26,627)

0.01

Atul Biospace Ltd

0.05

0.01

Atul China Ltd

0.02

0.03

Atul Europe Ltd

7.95

2.72

Atul Infotech Pvt Ltd

0.02

-

Atul Rajasthan Date Palms Ltd

–

0.05

Atul USA Inc

3.44

0.36

Other transactions

1 Loans given

4.92

8.06

Ameer Trading Corporation Ltd

4.12

3.76

Atul Bioscience Ltd

–

4.30

Atul Rajasthan Date Palms Ltd

0.80

–

2 Repayment of loan given

4.56

7.69

Ameer Trading Corporation Ltd

3.76

7.69

Atul Rajasthan Date Palms Ltd

0.80

–

3 Acquisition of investment for non-cash consideration

–

3.00

Atul Rajasthan Date Palms Ltd

–

3.00

4 Direct investments made

8.29

2.79

Equity share of Aasthan Dates Ltd

1.51

–

Equity share of Atul Bioscience Ltd

–

2.50

Equity share of Atul Biospace Ltd

3.41

–

Equity share of Atul Brasil Quimicos Ltda

–

0.29

Equity share of Biyaban Agri Ltd

0.74

–

Equity share of Raja Dates Ltd

2.63

–

5 Reimbursement received

0.11

–

Atul Bioscience Ltd

0.11

–

Outstanding balances as at year end

1 Loans receivable

8.42

8.06

Ameer Trading Corporation Ltd

4.12

3.76

Atul Bioscience Ltd

4.30

4.30

2 Receivables

82.49

60.30

Ameer Trading Corporation Ltd

0.01

0.01

Atul Bioscience Ltd

6.61

4.07

Atul Biospace Ltd

0.21

0.49

Atul China Ltd

12.71

0.68

Atul Deutschland GmbH

–

0.38

Atul Europe Ltd

26.71

26.92

Atul Rajasthan Date Palms Ltd

0.02

0.52

Atul USA Inc

36.22

27.23

3 Payables

7.52

4.13

Ameer Trading Corporation Ltd

0.15

0.13

Atul Bioscience Ltd

1.00

0.55

Atul Biospace Ltd

0.03

–

Atul China Ltd

0.27

0.23

Atul Deutschland GmbH

–

0.83

Atul Europe Ltd

3.77

1.26

Atul Infotech Pvt Ltd

0.57

0.63

Atul Rajasthan Date Palms Ltd (Current year:

`

28,597)

0.10

Atul USA Inc

1.73

0.40

Notes

to the Financial Statements